These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection? Sun HC; Zhang W Ann Surg; 2008 May; 247(5):900; author reply 900-1. PubMed ID: 18438131 [No Abstract] [Full Text] [Related]
33. Adjuvant therapy after curative treatment for hepatocellular carcinoma. Kudo M Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936 [TBL] [Abstract][Full Text] [Related]
34. Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B? Chien RN J Gastroenterol Hepatol; 2011 Dec; 26(12):1699-701. PubMed ID: 22097937 [No Abstract] [Full Text] [Related]
35. Hepatocellular carcinoma and vitamin K. Mizuta T; Ozaki I Vitam Horm; 2008; 78():435-42. PubMed ID: 18374204 [TBL] [Abstract][Full Text] [Related]
36. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)]. Yoshida H; Omata M Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842 [No Abstract] [Full Text] [Related]
39. The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients. Hiramatsu N; Yamada R; Takehara T J Gastroenterol Hepatol; 2016 Mar; 31(3):546-52. PubMed ID: 26574149 [TBL] [Abstract][Full Text] [Related]
40. Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy. Omata M; Yoshida H; Shiratori Y Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S141-3. PubMed ID: 16234063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]